USD 0.06
(1.59%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 20.93 Thousand USD | -79.07% |
2022 | 100 Thousand USD | 128.12% |
2021 | 43.83 Thousand USD | -88.73% |
2020 | 388.79 Thousand USD | -78.4% |
2019 | 1.79 Million USD | 404.32% |
2018 | 356.83 Thousand USD | -30.56% |
2017 | 513.87 Thousand USD | 108.65% |
2016 | 246.28 Thousand USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 25 Thousand USD | 19.42% |
2023 Q1 | 100 Thousand USD | 0.0% |
2023 Q4 | 20.93 Thousand USD | -62.91% |
2023 Q3 | 56.44 Thousand USD | -43.55% |
2023 Q2 | 100 Thousand USD | 0.0% |
2023 FY | 20.93 Thousand USD | -79.07% |
2022 Q3 | 100 Thousand USD | 6.41% |
2022 Q1 | 68.76 Thousand USD | 56.87% |
2022 FY | 100 Thousand USD | 128.12% |
2022 Q4 | 100 Thousand USD | 0.0% |
2022 Q2 | 93.97 Thousand USD | 36.65% |
2021 Q3 | 85.63 Thousand USD | -96.63% |
2021 FY | 43.83 Thousand USD | -88.73% |
2021 Q2 | 2.53 Million USD | 4.3% |
2021 Q1 | 2.43 Million USD | 11.1% |
2021 Q4 | 43.83 Thousand USD | -48.81% |
2020 Q4 | 2.18 Million USD | 0.0% |
2020 FY | 388.79 Thousand USD | -78.4% |
2019 FY | 1.79 Million USD | 404.32% |
2018 FY | 356.83 Thousand USD | -30.56% |
2017 Q4 | - USD | 0.0% |
2017 FY | 513.87 Thousand USD | 108.65% |
2016 FY | 246.28 Thousand USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
American Medical Technologies Inc. | 500 Thousand USD | 95.813% |
Ansell Limited | 855.59 Million USD | 99.998% |
Ansell Limited | 857.2 Million USD | 99.998% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 22.41 Million USD | 99.907% |
BioLife Sciences Inc. | - USD | -Infinity% |
Psykey, Inc. | 1.01 Million USD | 97.928% |
ConvaTec Group Plc | 1.31 Billion USD | 99.998% |
ConvaTec Group Plc | 1.31 Billion USD | 99.998% |
Encision Inc. | 1.33 Million USD | 98.43% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | 2.3 Million USD | 99.093% |
Innovative MedTech Inc. | 1.87 Million USD | 98.885% |
LifePoint, Inc. | 446.74 Thousand USD | 95.314% |
Medite Cancer Diagnostics, Inc. | 5.39 Million USD | 99.612% |
Paradigm Medical Industries, Inc. | 2.18 Million USD | 99.044% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | - USD | -Infinity% |
Reflect Scientific, Inc. | 242.64 Thousand USD | 91.372% |
SmileDirectClub, Inc. | 871.79 Million USD | 99.998% |
Sector 10, Inc. | 164 Thousand USD | 87.235% |
Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | 99.997% |
SheerVision, Inc. | 75 Thousand USD | 72.087% |
United Health Products, Inc. | 755.98 Thousand USD | 97.231% |
Vasamed, Inc. | 23.45 Thousand USD | 10.725% |
Wearable Health Solutions, Inc. | 2.76 Million USD | 99.244% |
Yubo International Biotech Limited | 790.49 Thousand USD | 97.352% |